Related Experiment Video
Updated: Mar 8, 2026
07:56
Sample Preparation of Mycobacterium tuberculosis Extracts for Nuclear Magnetic Resonance Metabolomic Studies
Published on: September 3, 2012
16.0K
Metabolomics biomarkers for tuberculosis diagnostics: current status and future objectives.
Ilse du Preez1, Laneke Luies1, Du Toit Loots1
1School for Physical & Chemical Sciences, Human Metabolomics, North-West University (Potchefstroom Campus), Private Bag x6001, Box 269, Potchefstroom, South Africa, 2531.
Biomarkers in Medicine
|January 19, 2017
Summary
Metabolomics research has identified new biomarkers for tuberculosis (TB) by studying host and microbe adaptations. These findings improve disease understanding, diagnostics, and potential clinical applications for TB control.
Area of Science:
- Biochemistry
- Microbiology
- Medical diagnostics
Background:
- Pulmonary tuberculosis (TB) is a complex infectious disease requiring ongoing research for effective control.
- Traditional research has advanced our understanding, but new approaches are needed for comprehensive insights.
Purpose of the Study:
- To review the role of metabolomics in tuberculosis research.
- To highlight the identification of novel biomarkers from host and microbial metabolome adaptations.
- To discuss the contribution of these biomarkers to disease characterization, diagnostics, and clinical applications.
Main Methods:
- Literature review focusing on metabolomics studies in tuberculosis.
- Analysis of identified biomarkers and their origins (host vs. microbe).
- Evaluation of biomarker utility in disease characterization and diagnostic development.
Main Results:
- Metabolomics has emerged as a key tool in understanding TB biology.
- Numerous biomarkers have been identified through the analysis of metabolic adaptations in TB.
- These biomarkers offer insights into disease mechanisms and have led to improved diagnostic strategies.
Conclusions:
- Metabolomics significantly contributes to the understanding of tuberculosis pathogenesis.
- Identified biomarkers hold potential for enhanced clinical applications in TB diagnosis and management.
- Continued research in metabolomics is crucial for advancing TB control strategies.
Related Concept Videos
01:26Pulmonary Tuberculosis IV
592
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
592
01:28Pulmonary Tuberculosis V
719
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
719
01:31Pulmonary Tuberculosis III
1.2K
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
1.2K
01:29Pulmonary Tuberculosis I
1.1K
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.1K
01:28Pulmonary Tuberculosis II
1.8K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.8K